Innovative Business Model
At Pharmaeconomica, we've reimagined drug discovery and development with a unique business model that maximizes collaboration, minimizes risk, and accelerates innovation. Our approach revolves around creating specialized spin-out companies for each new drug project.
Our core technology drives all our drug discovery efforts, keeping us at the forefront of pharmaceutical innovation.
Through spin-out companies, we segregate risk, safeguarding our parent company and concurrent projects from setbacks, and maintaining agility.
Our model streamlines decision-making processes, minimizes bureaucracy, and accelerates drug development
We assemble a project-specific team of partners and experts who excel in the targeted area, ensuring top-tier expertise.
Once incorporated, spin-out companies gain autonomy, raising funds tailored to their specific project needs.
With reduced risk, we can pursue multiple projects simultaneously, amplifying our potential to bring innovative therapies to market.